Angiotensin-(1-7): a new hormone of the angiotensin system.
about
An evolving story of angiotensin-II-forming pathways in rodents and humansEffect of aspirin on vasodilation to bradykinin and substance P in patients with heart failure treated with ACE inhibitorNovel Cardiac Intracrine Mechanisms Based on Ang-(1-12)/Chymase Axis Require a Revision of Therapeutic Approaches in Human Heart Disease.Development of fetal brain renin-angiotensin system and hypertension programmed in fetal originsTargeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension.Classical Renin-Angiotensin system in kidney physiologyRecent advances involving the renin-angiotensin systemACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good.Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice.Angiotensin-converting enzyme 2 deficiency is associated with impaired gestational weight gain and fetal growth restriction.Challenges posed to the maternal circulation by pregnancyRole of the vasodilator peptide angiotensin-(1-7) in cardiovascular drug therapyInternational Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].New frontiers in the intrarenal Renin-Angiotensin system: a critical review of classical and new paradigms.Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease.Intracrine angiotensin II functions originate from noncanonical pathways in the human heart.Significance of angiotensin 1-7 coupling with MAS1 receptor and other GPCRs to the renin-angiotensin system: IUPHAR Review 22.The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.Epoxyeicosatrienoic acid analog attenuates the development of malignant hypertension, but does not reverse it once established: a study in Cyp1a1-Ren-2 transgenic rats.Stages in Discovery: Angiotensin-Converting Enzyme Type 2 and Stroke.Angiotensin converting enzyme defects in shock: implications for future therapy
P2860
Q26830036-3CCDDA03-03E1-457A-9396-A4D8D06F541FQ28192376-EE16C535-F81D-4459-9F43-5D335661E15CQ30235583-6902F77F-1A6B-4EB8-A172-8A1E5E4819BFQ33641872-549FA723-C610-4051-881F-8FED6E8A6D58Q33684855-48DD4EA2-9AEB-4F86-8288-96B86944F00FQ34065655-43433877-B32D-42AA-A48C-C60D4CA38CC1Q34260674-AF751189-F0D9-487E-8D60-AD3ABD4891A3Q34784864-BFC1F95E-B219-4739-962A-659C21107C1BQ34830604-1F48E728-DAB5-4E70-AE17-AB3EA3867C44Q35587023-C010EBAD-BD4C-40C4-A22F-9DC6CA3ABD1AQ35602490-30DE1F67-03F5-4F99-86FF-017807F9D65AQ36013124-B235EA05-1AA0-4BF0-B4C3-C8863D17BA53Q36241932-DEF78FA1-60DC-4555-8F23-C19DD0403862Q37293326-273F835E-7D31-489E-AD8C-D35DD5E2DB45Q38750210-1FFFAF0E-1929-4D5A-9292-CA9E958C7B6DQ38846247-E9A134D0-ABC3-407C-9E18-BF5D53D6C04FQ39134595-8652DF06-05FA-417B-95D3-44BDE4AA2F42Q39376362-BDBC7E55-C08E-4205-9A43-47CB92EF204FQ41648482-F1F49643-4D89-4A66-872F-7DF193B6FCC6Q41826458-45913E11-1269-4F12-BC02-53694834FAEDQ58108305-E3B0375A-1D1A-43CA-B9C6-86B01D979F7A
P2860
Angiotensin-(1-7): a new hormone of the angiotensin system.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh
1991年學術文章
@zh-hant
name
Angiotensin-(1-7): a new hormone of the angiotensin system.
@en
type
label
Angiotensin-(1-7): a new hormone of the angiotensin system.
@en
prefLabel
Angiotensin-(1-7): a new hormone of the angiotensin system.
@en
P2093
P1433
P1476
Angiotensin-(1-7): a new hormone of the angiotensin system.
@en
P2093
C M Ferrario
E A Tallant
K B Brosnihan
M C Khosla
P304
P407
P433
P577
1991-11-01T00:00:00Z